Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
Go back to Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial| (NASDAQ: ELDN) | Delayed: 3.74 +0.02 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.72 | 52 Week High | $ | |||
| Open | $3.84 | 52 Week Low | $ | |||
| Day High | $3.84 | P/E | N/A | |||
| Day Low | $3.62 | EPS | $ | |||
| Volume | 505,372 | |||||
| (NASDAQ: NTRA) | Delayed: 265.05 +0.83 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $264.22 | 52 Week High | $13.80 | |||
| Open | $264.22 | 52 Week Low | $6.52 | |||
| Day High | $273.00 | P/E | N/A | |||
| Day Low | $261.59 | EPS | $0.00 | |||
| Volume | 409,886 | |||||
